Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19

Clinical trial NCT04306705 · UNKNOWN

Trial details

NCT number: NCT04306705
Sponsor: Tongji Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Covid-19 SARS Cytokine Storm Cytokine Release Syndrome Tocilizumab

Start date: 2020-02-20
Primary completion: 2020-05-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.